Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis

Ciurea, Adrian; Scherer, Almut; Weber, Ulrich; Exer, Pascale; Bernhard, Jürg; Tamborrini, Giorgio; Riek, Myriam; Müller, Rüdiger B; Weiss, Bettina; Nissen, Michaël; Kissling, Rudolf; Michel, Beat A; Finckh, Axel

doi:10.1136/annrheumdis-2013-205133

Scientific article

English

Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis

ContributorsCiurea, Adrian; Scherer, Almut; Weber, Ulrich; Exer, Pascale; Bernhard, Jürg; Tamborrini, Giorgio; Riek, Myriam; Müller, Rüdiger B; Weiss, Bettina; Nissen, Michaël; Kissling, Rudolf; Michel, Beat A; Finckh, Axel

Published inAnnals of the rheumatic diseases, vol. 75, no. 3, p. 532-539

Publication date2016

Abstract

To investigate the impact of smoking on the response to treatment with a first tumour necrosis factor inhibitor (TNFi) in patients with axial spondyloarthritis (axSpA) in a real-life cohort.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

CIUREA, Adrian et al. Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis. In: Annals of the rheumatic diseases, 2016, vol. 75, n° 3, p. 532–539. doi: 10.1136/annrheumdis-2013-205133

Article (Published version)

Identifiers

PID : unige:77889
DOI : 10.1136/annrheumdis-2013-205133
PMID : 25667205

Journal ISSN0003-4967

592views

0downloads

Creation10/09/2015 9:47:00 AM

First validation10/09/2015 9:47:00 AM

Update time02/03/2025 1:01:11 PM

Status update02/03/2025 1:01:11 PM

Last indexation02/03/2025 1:04:13 PM

Archive ouverte UNIGE

Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis

To investigate the impact of smoking on the response to treatment with a first tumour necrosis factor inhibitor (TNFi) in patients with axial spondyloarthritis (axSpA) in a real-life cohort.

Technical informations